Strategic Intent: Understanding Crossover Strategies in Biotech With Sofinnova Partners’ David Evans
Strategic Intent: Understanding Crossover Strategies in Biotech With Sofinnova Partners’ David Evans
AI 導讀
In this episode of Strategic Intent, Partner at Sofinnova Partners, David Evans discusses his transition from Roche Venture Fund, different investments strategies, general market analysis across Europe and US, as well as growing therapeutics area trends within biotech.
🎙️
Podcast 專家音訊節目
收錄於 888news Podcast 智庫專區，包含精華摘要與上市公司即時行情
正文 · AI 翻譯
在《Strategic Intent》本集，Sofinnova Partners 的合夥人 David Evans 討論他從 Roche Venture Fund 的轉變、不同的投資策略、歐洲與美國的市場概況，以及生物科技領域療法趨勢的成長。
來源： Citeline Podcasts (citeline.com)
開啟原文